Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

CL Vogel, MA Cobleigh, D Tripathy… - Journal of clinical …, 2002 - ascopubs.org
… of trastuzumab as first-line treatment of patients with … efficacy and preserves the QOL. In
conclusion, single-agent trastuzumab is an active and well tolerated option for first-line treatment

Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis

S Kanters, M Vitoria, M Doherty, ME Socias, N Ford… - The lancet HIV, 2016 - thelancet.com
… recommended a first-line antiretroviral therapy regimen that … the preferred option for first-line
therapy, although a ritonavir-… -based regimen can also be used in a first-line regimen in …

Efficacy and safety of first line treatments for patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: systematic review and …

YI Zhao, J Liu, X Cai, Z Pan, J Liu, W Yin, H Chen, Z Xie… - Bmj, 2019 - bmj.com
Objective To compare the efficacy and safety of first line treatments for patients with advanced
epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC). …

Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas

C Schiestl, K Neuhaus, S Zoller, U Subotic… - European journal of …, 2011 - Springer
… the high efficacy of propranolol as first-line treatment for … the good overall tolerance of
this therapy in young infants. … accurately investigate the efficacy and safety of propranolol …

The efficacy and safety of first-line chemotherapy in advanced esophagogastric cancer: a network meta-analysis

E Ter Veer, N Haj Mohammad… - Journal of the …, 2016 - academic.oup.com
… the efficacy and safety of first-line … NMA of first-line chemotherapy regimens is available yet.
Therefore, we conducted a systematic review to investigate the efficacy and safety of first-line

[HTML][HTML] The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis

E Ter Veer, NH Mohammad, P Lodder, LL Ngai… - Gastric Cancer, 2016 - Springer
… S-1 is first-line therapy for advanced … the efficacy and toxicity of S-1-based therapy compared
with 5-fluorouracil (5-FU)/capecitabine-based therapy and S-1-based combination therapy

Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: results …

X Pivot, A Schneeweiss, S Verma, C Thomssen… - European journal of …, 2011 - Elsevier
… We report exploratory sub-analyses of safety and efficacy in elderly patients, defined as ⩾65
years old, in AVastin And DOcetaxel (AVADO) receiving first-line bevacizumab plus …

… with docetaxel in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer administered as first-line treatment: the M77001 study …

M Marty, F Cognetti, D Maraninchi, R Snyder… - Journal of clinical …, 2005 - ascopubs.org
Purpose This randomized, multicenter trial compared first-line trastuzumab plus docetaxel
versus docetaxel alone in patients with human epidermal growth factor receptor 2 (HER2) –…

[HTML][HTML] Efficacy and safety of first-line systemic therapy for metastatic renal cell carcinoma: a systematic review and network meta-analysis

NA Bosma, MT Warkentin, CL Gan, S Karim… - European urology open …, 2022 - Elsevier
… Without head-to-head clinical trials of these different treatment options, we are reliant … efficacy,
safety, health-related quality of life, and patient-reported outcomes for first-line treatment of …

Efficacy and safety of contemporary dual-drug antiretroviral regimens as first-line treatment or as a simplification strategy: a systematic review and meta-analysis

AC Achhra, G Mwasakifwa, J Amin, MA Boyd - The Lancet HIV, 2016 - thelancet.com
… and toxicity and preserving future treatment options. We aimed to assess the efficacy and
safety of dual-therapy versus triple therapy as first-line treatment or in treatment simplification. …